| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18445 R78344 |
Lee (Controls exposed to SSRI), 2025 | Admission to neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: TCA only |
1.23 [0.72;2.10] C excluded (control group) |
21/613 41/1,465 | 62 | 613 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18410 R77745 |
Lee (Controls unexposed, general pop), 2025 | Admission to neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: TCA only | 1.10 [0.70;1.71] | 21/613 8,566/463,440 | 8,587 | 613 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10933 R41685 |
Reis (Controls exposed to SSRIs), 2010 | Respiratory diagnoses | 2nd and/or 3rd trimester | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: TCA only |
1.61 [1.25;2.08] C excluded (control group) |
83/784 329/4,809 | 412 | 784 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10934 R41679 |
Reis (Controls unexposed, NOS), 2010 | Respiratory diagnoses | 2nd and/or 3rd trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: TCA only | 2.50 [1.99;3.14] | 83/784 57,487/1,062,190 | 57,570 | 784 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10930 R40633 |
Davis, 2007 | Respiratory distress syndrome and other respiratory conditions | 3rd trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 2.02 [1.33;3.06] | 19/136 5,393/75,957 | 5,412 | 136 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11218 R41283 |
Pearson (Controls exposed to SSRIs), 2007 | Admission in Special care nursery of neonatal intensive care unit | during pregnancy (anytime or not specified) | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: TCA only |
3.13 [0.97;10.09] C excluded (control group) |
11/37 5/42 | 16 | 37 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11217 R41280 |
Pearson (Controls unexposed, NOS), 2007 | Admission in Special care nursery of neonatal intensive care unit | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: TCA only | 3.76 [1.58;8.93] C | 11/37 17/168 | 28 | 37 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 2.03 [1.32;3.11] | 71,597 | 1,570 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, general pop; 2: Controls unexposed, NOS; 3: Controls unexposed, NOS;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 11218, 10933, 18445